Healthcare innovator and former Accenture
executive brings deep industry relationships to advance Dario's
AI-driven chronic care platform.
NEW
YORK, Feb. 27, 2025 /PRNewswire/ -- DarioHealth
Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in
AI-driven digital health solutions, today announced the appointment
of Lawrence (Larry) B. Leisure to
its Board of Directors, bringing four decades of healthcare
leadership, managed care expertise, and digital health innovation
to the company's governance. Mr. Leisure's extensive experience
working with health plans, health systems, consultants, and
employer coalitions, combined with his deep understanding of health
policy, reimbursement, and value-based care models, will be
instrumental in guiding Dario's continued expansion within the
payer and employer markets.

Mr. Leisure began his professional career in benefits consulting
ultimately serving as National Practice Leader at Towers Perrin
(aka Willis Towers Watson) then
transitioning to management consulting first as a Senior Partner at
PricewaterhouseCoopers and later as a Managing Partner at
Accenture. He went on to serve in senior leadership roles at Kaiser
Foundation Health Plan and UnitedHealth Group's OptumInsight
unit. His pivot to health care investing started with his joining
the venture capital firm of Kleiner
Perkins as an Operating Partner. In 2014, he co-founded
Chicago Pacific Founders, a health care focused private equity
firm.
As an ardent advocate for innovation in healthcare, Mr. Leisure
co-founded the Employer Health Innovation Roundtable, a coalition
representing over six million lives. Mr. Leisure is Chairman of the
UCSF Rosenman Institute, member of the UCLA Anderson School of
Management Board of Advisors, and a Senior Advisor at the Mussalem
Center for BIODESIGN at Stanford
University.
He received his BA in Economics from Stanford University and his MBA in Finance from the
UCLA Anderson School of Management. He resides in Atherton, California with his wife, Bren.
"We are honored to welcome Larry to Dario's Board of Directors,"
said Erez Raphael, CEO of Dario.
"His deep expertise across the healthcare ecosystem—from payers and
employer groups and healthcare innovators—will provide invaluable
insight as we continue to scale our solutions and strengthen our
value-based partnerships. Larry's leadership in advancing
healthcare technology and his track record of driving meaningful
industry change align perfectly with Dario's mission to deliver
better health outcomes through AI-driven, personalized care."
About DarioHealth Corp.
DarioHealth Corp. (Nasdaq: DRIO) is a leading digital health
company revolutionizing how people with chronic conditions manage
their health through a user-centric, multi-chronic condition
digital therapeutics platform. Dario's platform and suite of
solutions deliver personalized and dynamic interventions driven by
data analytics and one-on-one coaching for diabetes, hypertension,
weight management, musculoskeletal pain and behavioral
health.
Dario's user-centric platform offers people continuous and
customized care for their health, disrupting the traditional
episodic approach to healthcare. This approach empowers people to
holistically adapt their lifestyles for sustainable behavior
change, driving exceptional user satisfaction, retention and
results and making the right thing to do the easy thing to do.
Dario provides its highly user-rated solutions globally to
health plans and other payers, self-insured employers, providers of
care and consumers. To learn more about Dario and its digital
health solutions, or for more information, visit
http://dariohealth.com.
Cautionary Note Regarding Forward-Looking Statements
This news release and the statements of representatives and
partners of DarioHealth Corp. related thereto contain or may
contain forward-looking statements within the meaning of the
Private Securities Litigation Reform Act of 1995. Statements that
are not statements of historical fact may be deemed to be
forward-looking statements. For example, the Company is using
forward-looking statements in this press release when it discusses
its belief that adding Mr. Leisure as a member of the Board will be
instrumental in guiding Dario's continued expansion within the
payer and employer markets and to advance Dario's AI-driven chronic
care platform. Without limiting the generality of the foregoing,
words such as "plan," "project," "potential," "seek," "may,"
"will," "expect," "believe," "anticipate," "intend," "could,"
"estimate" or "continue" are intended to identify forward-looking
statements. Readers are cautioned that certain important factors
may affect the Company's actual results and could cause such
results to differ materially from any forward-looking statements
that may be made in this news release. Factors that may affect the
Company's results include, but are not limited to, regulatory
approvals, product demand, market acceptance, impact of competitive
products and prices, product development, commercialization or
technological difficulties, the success or failure of negotiations
and trade, legal, social and economic risks, and the risks
associated with the adequacy of existing cash resources. Additional
factors that could cause or contribute to differences between the
Company's actual results and forward-looking statements include,
but are not limited to, those risks discussed in the Company's
filings with the U.S. Securities and Exchange Commission. Readers
are cautioned that actual results (including, without limitation,
the timing for and results of the Company's commercial and
regulatory plans for Dario™ as described herein) may differ
significantly from those set forth in the forward-looking
statements. The Company undertakes no obligation to publicly update
any forward-looking statements, whether as a result of new
information, future events or otherwise, except as required by
applicable law.
DarioHealth Corporate Contact
Mary Mooney
VP Marketing
mary@dariohealth.com
+1-312-593-4280
DarioHealth Investor Relations Contact
Kat
Parrella
Investor Relations Manager
kat@dariohealth.com
+315-378-6922
Logo:
https://mma.prnewswire.com/media/1920436/3708722/DarioHealth_Logo.jpg
View original
content:https://www.prnewswire.com/news-releases/dariohealth-appoints-healthcare-industry-leader-larry-leisure-to-board-of-directors-302387341.html
SOURCE DarioHealth Corp.